Agersnap, Mikkel Askjær http://orcid.org/0000-0002-5827-5870
Sonne, Kim
Knudsen, Kim Mark
Sulowicz, Wladyslaw
Article History
Accepted: 18 January 2023
First Online: 21 February 2023
Change Date: 13 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40262-023-01236-4
Declarations
:
: Zealand Pharma A/S sponsored the study
: KMK is employed at Zealand Pharma. MAA and KS were formerly employed at Zealand Pharma. WS has nothing to declare.
: Provided upon request.
: Provided upon request.
: Zealand Pharma A/S was involved in the design (KS, KMK and MAA designed the trial) and conduct of the study, analysis, and interpretation of the data, including collection, management, and statistical analysis of the data. KMK is an employee of Zealand Pharma. MAA and KS are former employees of Zealand Pharma. The authors had full access to the clinical trial report and associated documents. WS was a trial investigator and helped obtain data. MAA was the medical responsible for the trial and KMK was responsible for the statistical considerations and analyses. All authors were involved in drafting the manuscript or revising it critically for important intellectual content, approved the final version to be published, and take full responsibility for the accuracy and integrity of the content.
: The trial protocol, consent form and other information provided to subjects were approved by independent ethics committees and by competent authorities.
: Written informed consent was obtained from subjects before trial enrollment.
: All authors approved the manuscript for submission.